These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 20136824)
1. Increased adhesive properties of platelets in sickle cell disease: roles for alphaIIb beta3-mediated ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activity. Proença-Ferreira R; Franco-Penteado CF; Traina F; Saad ST; Costa FF; Conran N Br J Haematol; 2010 Apr; 149(2):280-8. PubMed ID: 20136824 [TBL] [Abstract][Full Text] [Related]
2. Endothelial activation by platelets from sickle cell anemia patients. Proença-Ferreira R; Brugnerotto AF; Garrido VT; Dominical VM; Vital DM; Ribeiro Mde F; dos Santos ME; Traina F; Olalla-Saad ST; Costa FF; Conran N PLoS One; 2014; 9(2):e89012. PubMed ID: 24551209 [TBL] [Abstract][Full Text] [Related]
3. Increasing susceptibility of nitric oxide-mediated inhibitory platelet signaling during storage of apheresis-derived platelet concentrates. Kobsar A; Klinker E; Kuhn S; Koessler A; Yilmaz P; Boeck M; Koessler J Transfusion; 2014 Jul; 54(7):1782-9. PubMed ID: 24576258 [TBL] [Abstract][Full Text] [Related]
4. Distinct but critical roles for integrin alphaIIbbeta3 in platelet lamellipodia formation on fibrinogen, collagen-related peptide and thrombin. Thornber K; McCarty OJ; Watson SP; Pears CJ FEBS J; 2006 Nov; 273(22):5032-43. PubMed ID: 17032352 [TBL] [Abstract][Full Text] [Related]
5. Altered red cell and platelet adhesion in hemolytic diseases: Hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria and sickle cell disease. Sakamoto TM; Canalli AA; Traina F; Franco-Penteado CF; Gambero S; Saad ST; Conran N; Costa FF Clin Biochem; 2013 Dec; 46(18):1798-803. PubMed ID: 24060729 [TBL] [Abstract][Full Text] [Related]
6. Decreasing phosphodiesterase 5A activity contributes to platelet cGMP accumulation during storage of apheresis-derived platelet concentrates. Kobsar A; Putz E; Yilmaz P; Weinig E; Boeck M; Koessler J Transfusion; 2014 Apr; 54(4):1008-14. PubMed ID: 23909451 [TBL] [Abstract][Full Text] [Related]
7. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473 [TBL] [Abstract][Full Text] [Related]
8. Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A. Zhang W; Colman RW Blood; 2007 Sep; 110(5):1475-82. PubMed ID: 17392505 [TBL] [Abstract][Full Text] [Related]
9. Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels. Sim DS; Merrill-Skoloff G; Furie BC; Furie B; Flaumenhaft R Blood; 2004 Mar; 103(6):2127-34. PubMed ID: 14645013 [TBL] [Abstract][Full Text] [Related]
10. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa]. Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599 [TBL] [Abstract][Full Text] [Related]
11. Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease. Garrido VT; Proença-Ferreira R; Dominical VM; Traina F; Bezerra MA; de Mello MR; Colella MP; Araújo AS; Saad ST; Costa FF; Conran N Br J Haematol; 2012 Sep; 158(6):788-97. PubMed ID: 22775554 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of ADP-induced platelet adhesion to immobilised fibrinogen by nitric oxide: evidence for cGMP-independent mechanisms. Oberprieler NG; Roberts W; Graham AM; Homer-Vanniasinkam S; Naseem KM Biochem Pharmacol; 2007 May; 73(10):1593-601. PubMed ID: 17306768 [TBL] [Abstract][Full Text] [Related]
14. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls. Reininger AJ; Agneskirchner J; Bode PA; Spannagl M; Wurzinger LJ Thromb Haemost; 2000 Feb; 83(2):217-23. PubMed ID: 10739376 [TBL] [Abstract][Full Text] [Related]
15. Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation. Ito H; Miyakoda G; Mori T Platelets; 2004 Aug; 15(5):293-301. PubMed ID: 15370100 [TBL] [Abstract][Full Text] [Related]
16. High expression of the cGMP-specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition in erythroid cells and SCD neutrophils. Almeida CB; Traina F; Lanaro C; Canalli AA; Saad ST; Costa FF; Conran N Br J Haematol; 2008 Sep; 142(5):836-44. PubMed ID: 18564357 [TBL] [Abstract][Full Text] [Related]